Abiopharma

LOEWS CORP (L) Reports the reporting period Financial Results LOEWS CORP (L) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 1261
• Net Income: 26
• EPS: Not disclosed
• Cash and equivalents: $1
  • expected by the Company. A discussion of the important risk factors and other considerations that could materially impact these matters, as well as the Company’s overall business and financial performance, can be found in the Company’s reports filed with the Securities and Exchange Commission and readers of this release are urged to review those reports carefully when considering these forward-looking statements. Copies of these reports are available through the Company’s website (www.loews.com). Given these risk factors, investors and analysts should not place undue reliance on forward-looking statements. Any such forward-looking statements speak only as of the date of this news release. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement to reflect any change in the Company’s expectations with regard thereto or any change in events, conditions or circumstances on which any forward-looking statement is based.Investor relations and media relations contact:Chris Nugent1-212-521-2403